Angiotensin-Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction | New England Journal of Medicine | 2019 | 705 |
Clinical practice update on heart failure 2019: pharmacotherapy, procedures, devices and patient management. An expert consensus meeting report of the Heart Failure Association of the European Society of Cardiology | European Journal of Heart Failure | 2019 | 325 |
Durability of a primary care-led weight-management intervention for remission of type 2 diabetes: 2-year results of the DiRECT open-label, cluster-randomised trial | Lancet Diabetes and Endocrinology,the | 2019 | 273 |
Withdrawal of pharmacological treatment for heart failure in patients with recovered dilated cardiomyopathy (TRED-HF): an open-label, pilot, randomised trial | Lancet, The | 2019 | 198 |
Intravenous Iron in Patients Undergoing Maintenance Hemodialysis | New England Journal of Medicine | 2019 | 187 |
Outcome in Dilated Cardiomyopathy Related to the Extent, Location, and Pattern of Late Gadolinium Enhancement | JACC: Cardiovascular Imaging | 2019 | 103 |
Towards better definition, quantification and treatment of fibrosis in heart failure. A scientific roadmap by the Committee of Translational Research of the Heart Failure Association (HFA) of the European Society of Cardiology | European Journal of Heart Failure | 2019 | 99 |
Heart failure in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference | Kidney International | 2019 | 96 |
Morbidity, mortality and missed appointments in healthcare: a national retrospective data linkage study | BMC Medicine | 2019 | 92 |
Cardiac Troponin T and Troponin I in the General Population | Circulation | 2019 | 90 |
The rise and fall of aspirin in the primary prevention of cardiovascular disease | Lancet, The | 2019 | 85 |
Effect of Low-Dose Intracoronary Alteplase During Primary Percutaneous Coronary Intervention on Microvascular Obstruction in Patients With Acute Myocardial Infarction: A Randomized Clinical Trial | JAMA - Journal of the American Medical Association | 2019 | 54 |
Association Between Levothyroxine Treatment and Thyroid-Related Symptoms Among Adults Aged 80 Years and Older With Subclinical Hypothyroidism | JAMA - Journal of the American Medical Association | 2019 | 47 |
Temporal Trends and Patterns in Mortality After Incident Heart Failure: A Longitudinal Analysis of 86 000 Individuals | JAMA Cardiology | 2019 | 45 |
Identification of Frailty in Chronic Heart Failure | JACC: Heart Failure | 2019 | 44 |
Effects and moderators of exercise on muscle strength, muscle function and aerobic fitness in patients with cancer: a meta-analysis of individual patient data | British Journal of Sports Medicine | 2019 | 43 |
Functional Outcome of Intravenous Thrombolysis in Patients With Lacunar Infarcts in the WAKE-UP Trial | JAMA Neurology | 2019 | 40 |
Ischemia and No Obstructive Coronary Artery Disease: Prevalence and Correlates of Coronary Vasomotion Disorders | Circulation: Cardiovascular Interventions | 2019 | 39 |
A comprehensive analysis of the effects of rivaroxaban on stroke or transient ischaemic attack in patients with heart failure, coronary artery disease, and sinus rhythm: the COMMANDER HF trial | European Heart Journal | 2019 | 38 |
Adherence to cardiovascular medication: a review of systematic reviews | Journal of Public Health | 2019 | 37 |
The effect of a programme to improve men's sedentary time and physical activity: The European Fans in Training (EuroFIT) randomised controlled trial | PLoS Medicine | 2019 | 36 |
β-blockers, calcium antagonists, and mortality in stable coronary artery disease: an international cohort study | European Heart Journal | 2019 | 35 |
Association of Rivaroxaban With Thromboembolic Events in Patients With Heart Failure, Coronary Disease, and Sinus Rhythm: A Post Hoc Analysis of the COMMANDER HF Trial | JAMA Cardiology | 2019 | 34 |
Proteomic Bioprofiles and Mechanistic Pathways of Progression to Heart Failure | Circulation: Heart Failure | 2019 | 33 |
Predictive validity of preschool screening tools for language and behavioural difficulties: A PRISMA systematic review | PLoS ONE | 2019 | 29 |